The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: Cellular mechanisms and clinical implications

Oliver P. Flint, Mustafa A. Noor, Paul W. Hruz, Phil B. Hylemon, Kevin Yarasheski, Donald P. Kotler, Rex A. Parker, Aouatef Bellamine

Research output: Contribution to journalReview articlepeer-review

70 Scopus citations

Abstract

Metabolic complications associated with HIV infection and treatment frequently present as a relative lack of peripheral adipose tissue associated with dyslipidemia and insulin resistance. In this review we explain the connection between abnormalities of intermediary metabolism, observed either in vitro or in vivo, and this group of metabolic effects. We review molecular mechanisms by which the HIV protease inhibitor (PI) class of drugs may affect the normal stimulatory effect of insulin on glucose and fat storage. We then propose that both chronic inflammation from HIV infection and treatment with some drugs in this class trigger cellular homeostatic stress responses with adverse effects on intermediary metabolism. The physiologic outcome is such that total adipocyte storage capacity is decreased, and the remaining adipocytes resist further fat storage. The excess circulating and dietary lipid metabolites, normally "absorbed" by adipose tissue, are deposited ectopically in lean (muscle and liver) tissue, where they impair insulin action. This process leads to a pathologic cycle of lipotoxicity and lipoatrophy and a clinical phenotype of body fat distribution with elevated waist-to-hip ratio similar to the metabolic syndrome.

Original languageEnglish
Pages (from-to)65-77
Number of pages13
JournalToxicologic Pathology
Volume37
Issue number1
DOIs
StatePublished - Jan 2009

Keywords

  • Cardiovascular disease
  • Clinical pathology
  • Dyslipidemia
  • Endocrine system
  • In vitro toxicology
  • Insulin resistance
  • Lipodystrophy
  • Mechanisms of toxicity
  • Molecular pathology
  • Pharmaceutical development/products
  • Protease inhibitors

Fingerprint

Dive into the research topics of 'The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: Cellular mechanisms and clinical implications'. Together they form a unique fingerprint.

Cite this